Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

CGEMCGEM
Showing 5 of 12 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in CULLINAN THERAPEUTICS INC

AQR CAPITAL MANAGEMENT LLC holds 581,338 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $10.6M as of 2026-Q2. The position was increased (+61.1% shares). CGEM represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$10.6M

Current Shares

581,338

Total Value Change

+$10.4M

Total Shares Change

+560,418

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
581,338
+61.1%
$10.6M0.0%$18.21
40
2026-Q1
Increased
360,874
+28.2%
$5.1M0.0%$15.73
34
2025-Q4
Increased
281,483
+42.2%
$2.9M0.0%$9.92
35
2025-Q3
Increased
197,920
+846.1%
$1.2M0.0%$5.97
41
2025-Q2
New
20,920
-
$157,5280.0%$7.76
31

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used